a month ago
JAZZ
AnalystsJoseph ThomeJoseph Thome's Stock Forecasts
AnalystsJoseph Thome
Sectors:
Analyst Ranking
Bottom 7%
#5156 out of 5500 analysts
Average Return
-3.42%
Win Rate
50%19 out of 38
Risk vs Reward
Poor
Good
Joseph Thome's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Axsome Therapeutics IncAXSM | +105.48% | $36.49 | $74.98 | 2022-06-29 - 2023-06-28 | Buy |
Marinus Pharmaceuticals IncMRNS | +75.09% | $10.68 | $18.70 | 2020-07-01 - 2021-07-01 | Buy |
Intra Cellular Therapies IncITCI | +71.95% | $76.69 | $131.87 | 2024-04-17 - 2025-04-01 | Strong Buy |
Cerevel Therapeutics Holdings IncCERE | +65.81% | $24.86 | $41.22 | 2023-04-10 - 2023-12-08 | Buy |
Viridian Therapeutics IncVRDN | +49.36% | $21.03 | $31.41 | 2024-11-25 - 2025-11-25 | Strong Buy |
Joseph Thome Analyst Color
Get additional color on Joseph Thome's coverage of popular stocks
4 months ago
JAZZ
Joseph Thome's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Anaptysbio IncANAB | 1 | Strong Buy | $70.00 | +26.63% | Maintains | 8 days ago |
Ardelyx IncARDX | 2 | Strong Buy | $10.00 | +165.96% | Maintains | a month ago |
Mirum Pharmaceuticals IncMIRM | 5 | Strong Buy | $140.00 | +42.36% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 2 | Strong Buy | $300.00 | +23.10% | Maintains | a month ago |
Dyne Therapeutics IncDYN | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 months ago |
Alkermes PLCALKS | 2 | Strong Buy | $50.00 | +5.93% | Maintains | 2 months ago |
Axsome Therapeutics IncAXSM | 3 | Strong Buy | $300.00 | +47.91% | Maintains | 3 months ago |
Precision Biosciences IncDTIL | 1 | Buy | $20.00 | +161.78% | Initiates Coverage On | 3 months ago |
Ptc Therapeutics IncPTCT | 4 | Strong Buy | $90.00 | +27.55% | Upgrades | 4 months ago |
Maplight Therapeutics IncMPLT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 5 months ago |
United Therapeutics CorpUTHR | 4 | Strong Buy | $660.00 | +28.73% | Maintains | 5 months ago |
Bright Minds Biosciences IncDRUG | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Viridian Therapeutics IncVRDN | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Intra Cellular Therapies IncITCI | 2 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Prime Medicine IncPRME | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Metagenomi Therapeutics IncMGX | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Cerevel Therapeutics Holdings IncCERE | 2 | Hold | $45.00 | N/A | Downgrades | 3 years ago |
Evelo Biosciences IncEVLO | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Y Mabs Therapeutics IncYMAB | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Acrivon Therapeutics IncACRV | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Third Harmonic Bio IncTHRD | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Epizyme IncEPZM | 1 | Hold | $1.50 | N/A | Downgrades | 4 years ago |
Intellia Therapeutics IncNTLA | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Entrada Therapeutics IncTRDA | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Jade Biosciences IncJBIO | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Allakos IncALLK | 1 | Buy | N/A | N/A | Initiates Coverage On | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.